新生儿与婴儿期起病癫痫及癫痫综合征全球流行病学:系统综述与荟萃分析
该系统综述与荟萃分析纳入30个国家86项人群观察性研究,估计婴儿期起病癫痫2岁内累积发病率为每10万活产236.0例(95%CI 164.7-338.2)。发育性癫痫性脑病(DEE)发病率最高(67.7/10万活产),其中婴儿癫痫性痉挛综合征(IESS)最常见(31.6/10万活产)。研究间异质性大,估计值应视为广泛指标而非精确率。
要点
- 婴儿期起病癫痫2岁内累积发病率约236.0/10万活产。
- DEE发病率居首,IESS是最常见的DEE亚型。
- 自限性癫痫中自限性婴儿癫痫发病率最高。
核心结论
- 新生儿与婴儿期起病癫痫全球负担显著,主要由DEE尤其是IESS驱动。
- 因研究间异质性大,合并估计值应视为广泛指标而非精确可推广率。
- 非洲和东地中海区域数据缺乏,需在代表性不足地区开展人群研究及纵向研究。
研究设计与样本
- 纳入报告新生儿或婴儿期起病癫痫或癫痫综合征发病率或患病率的人群观察性研究。
- 共纳入30个国家4个WHO区域的86项人群研究,采用广义线性混合模型随机效应荟萃分析合并估计。
主要发现
- 婴儿期起病癫痫2岁内合并累积发病率为每10万活产236.0例(95%CI 164.7-338.2;95%PI 53.0-1044.3)。
- DEE合并发病率为每10万活产67.7例(95%CI 42.1-108.9;95%PI 7.1-636.1)。
- IESS合并发病率为每10万活产31.6例(95%CI 27.5-36.2;95%PI 13.7-72.6),为最常见的DEE。
- 自限性婴儿癫痫合并发病率为每10万活产13.0例(95%CI 9.2-18.2;95%PI 6.4-26.4),为自限性癫痫中最高。
临床怎么用
- 可参考上述发病率估计规划新生儿与婴儿期癫痫的筛查、诊断和医疗资源配置。
- DEE和IESS负担最高,临床应优先关注早期识别与干预。
- 解释流行病学数据时需考虑地域差异和异质性,避免直接套用为本地精确率。
局限性
- 研究间存在显著异质性。
- 地理代表性有限,多数研究来自欧洲区域高收入国家,非洲和东地中海区域数据缺乏。
- 合并估计值应解释为广泛指标而非精确可推广率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite the profound impact of neonatal and infantile-onset epilepsies on neurodevelopmental outcomes and mortality, consolidated global epidemiological evidence remains lacking. OBJECTIVES: To estimate the global incidence and prevalence of neonatal and infantile-onset epilepsies and epilepsy syndromes and to characterize their associated etiological profiles. DATA SOURCES: PubMed, Embase, Web of Science, and Scopus were searched from inception through December 18, 2025. STUDY SELECTION: Population-based observational studies reporting the incidence or prevalence of neonatal and infantile-onset epilepsies or epilepsy syndromes were eligible for inclusion. DATA EXTRACTION AND SYNTHESIS: Two authors independently and in duplicate performed study selection, data extraction, and quality assessment of included studies using the Joanna Briggs Institute Critical Appraisal checklist for prevalence studies. Generalized linear mixed-model random-effects meta-analysis was used to pool the estimates of incidence, prevalence, and etiology. Subgroup meta-analyses were conducted by country, World Health Organization (WHO) region, World Bank income, and diagnostic criteria. Metaregression was used to investigate the association between study-level covariates and pooled incidence estimates of infantile-onset epilepsy syndromes. MAIN OUTCOMES AND MEASURES: Cumulative incidence and prevalence of neonatal and infantile-onset epilepsies and epilepsy syndromes. RESULTS: A total of 86 population-based studies from 30 countries across 4 WHO regions were included. The pooled cumulative incidence of infantile-onset epilepsies within the first 2 years of life was 236.0 cases (95% CI, 164.7-338.2; 95% prediction interval [PI], 53.0-1044.3) per 100 000 live births. Among epilepsy syndrome subgroups, developmental and epileptic encephalopathies (DEEs) had the highest incidence at 67.7 cases (95% CI, 42.1-108.9; 95% PI, 7.1-636.1) per 100 000 live births. Infantile epileptic spasms syndrome (IESS) was the most incident DEE, with 31.6 cases (95% CI, 27.5-36.2; 95% PI, 13.7-72.6) per 100 000 live births. Among self-limited epilepsies, self-limited infantile epilepsy had the highest incidence at 13.0 cases (95% CI, 9.2-18.2; 95% PI, 6.4-26.4) per 100 000 live births. Subgroup analyses revealed limited geographical representativeness, with the majority of studies from high-income countries in the European Region. CONCLUSIONS AND RELEVANCE: The findings underscore a significant global burden of neonatal and infantile-onset epilepsies, primarily driven by DEEs, specifically IESS. Given substantial between-study heterogeneity, the pooled estimates should be interpreted as broad indicators rather than precise, generalizable rates. Geographic disparities, with a lack of data from the African and Eastern Mediterranean Regions, underscore the need for population-based studies in underrepresented regions and longitudinal research on survival, remission, and functional outcomes.
引用
- Safeer V S M, Singh A, Nahan N, et al. Global Epidemiology of Neonatal and Infantile-Onset Epilepsies and Epilepsy Syndromes (GENIE): A Systematic Review and Meta-Analysis. JAMA Neurol. 2026. PMID: 42970304. doi:10.1001/jamaneurol.2026.3906
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。